UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial

European urology, 2020-08, Vol.78 (2), p.184-192

2020

Volltextzugriff (PDF)

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2022-06, Vol.28 (11), p.2237-2247

2022

Volltextzugriff (PDF)

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer

Advances in therapy, 2023-11, Vol.40 (11), p.4919-4927

2023

Volltextzugriff (PDF)

eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer

Clinical genitourinary cancer, 2018-04, Vol.16 (2), p.149-154

2018

Volltextzugriff (PDF)

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

The New England journal of medicine, 2019-07, Vol.381 (1), p.13-24

2019

Volltextzugriff (PDF)

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

The New England journal of medicine, 2020-12, Vol.383 (24), p.2345-2357

2020

Volltextzugriff (PDF)

Time to chemotherapy following treatment with sipuleucel-T: Data from PROCEED

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5040-5040

2014

Volltextzugriff (PDF)

Evaluation of retropulsion caused by holmium:YAG laser with various power settings and fibers

Journal of endourology, 1998-04, Vol.12 (2), p.183-186

1998

Volltextzugriff (PDF)

Event-driven data acquisition: Using ADALAB with an Acculab Infrared Spectrometer

Journal of chemical education, 1986-04, Vol.63 (4), p.323

1986

Volltextzugriff (PDF)

Experimental utilization of the holmium laser in a model of ureteroscopic lithotripsy : Energy analysis

Journal of endourology, 1999-03, Vol.13 (2), p.113-115

1999

Volltextzugriff (PDF)

Endoscopic subcutaneous neurovascular lower-extremity myofascial flap harvesting for genitourinary reconstruction

Journal of endourology, 1998-04, Vol.12 (2), p.187-191

1998

Volltextzugriff (PDF)

Assessment of access strategies for fetoscopic urologic surgery : Preliminary results

Journal of endourology, 1997-02, Vol.11 (1), p.49-53

1997

Volltextzugriff (PDF)

Minimally traumatic techniques for in utero access and fetal surgery

Journal of the Society of Laparoendoscopic Surgeons, 1998-07, Vol.2 (3), p.227-233

1998

Volltextzugriff (PDF)

Amnioscopic endofetal illumination with infrared-guided fiber

Journal of endourology, 1997-08, Vol.11 (4), p.259-261

1997

Volltextzugriff (PDF)

Impact of concomitant cardiovascular therapies on efficacy and safety of relugolix verus leuprolide in men with advanced prostate cancer: Subgroup analysis from the phase 3 HERO study

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.101-101

2022

Volltextzugriff (PDF)

Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT)

Clinical genitourinary cancer, 2019-12, Vol.17 (6), p.457-463.e6

2019

Volltextzugriff (PDF)

MP27-16 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

PD35-08 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: POOLED SAFETY ANALYSES FROM RANDOMIZED CONTROLLED STUDIES

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

MP83-10 PROSTATE CANCER ACTIVE SURVEILLANCE QUALITY IN LARGE COMMUNITY UROLOGY PRACTICES

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States

Urology (Ridgewood, N.J.), 2019-07, Vol.129, p.79-86

2019

Volltextzugriff (PDF)

Hereditary cancer risk assessment and genetic testing in the community urology practice setting

The Prostate, 2022-05, Vol.82 (7), p.850-857

2022

Volltextzugriff (PDF)

LB-S&T-12 OPEN -LABEL PHASE II STUDY EVALUATING THE EFFICACY OF CONCURRENT ADMINISTRATION OF RADIUM RA 223 DICHLORIDE AND ABIRATERONE ACETATE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH SYMPTOMATIC BONE METASTASES (ERADICATE)

The Journal of urology, 2016-04, Vol.195 (4), p.e340-e340

2016

Volltextzugriff (PDF)

Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States

Urology (Ridgewood, N.J.), 2019-08, Vol.130, p.72-78

2019

Volltextzugriff (PDF)

Real-world study of enzalutamide and abiraterone acetate (with prednisone) tolerability (REAAcT): Results

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.296-296

2018

Volltextzugriff (PDF)

Phase 1b/2 study of enzalutamide (ENZ) with LY3023414 (LY) or placebo (PL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) after progression on abiraterone

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5009-5009

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(12)
Male
(11)
Urology & Nephrology
(11)
Aged
(7)
Middle Aged
(6)
Treatment Outcome
(6)
Oncology
(5)
Prostate Cancer
(5)
Aged, 80 And Over
(4)
Animals
(4)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Female
(3)
Patients
(3)
Pregnancy
(3)
Prospective Studies
(3)
Prostatic Neoplasms, Castration-Resistant - Pathology
(3)
Quality Of Life
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Oral Gonadotropin-releasing Hormone Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant Androgen Deprivation Therapy to External Beam Radiotherapy in Patients with Localised Intermediate-risk Prostate Cancer: A Randomised, Open-label, Parallel-group Phase 2 Trial

Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer

Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer

eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

Time to chemotherapy following treatment with sipuleucel-T: Data from PROCEED

Evaluation of retropulsion caused by holmium:YAG laser with various power settings and fibers

Event-driven data acquisition: Using ADALAB with an Acculab Infrared Spectrometer

Experimental utilization of the holmium laser in a model of ureteroscopic lithotripsy : Energy analysis

Endoscopic subcutaneous neurovascular lower-extremity myofascial flap harvesting for genitourinary reconstruction

Assessment of access strategies for fetoscopic urologic surgery : Preliminary results

Minimally traumatic techniques for in utero access and fetal surgery

Amnioscopic endofetal illumination with infrared-guided fiber

Impact of concomitant cardiovascular therapies on efficacy and safety of relugolix verus leuprolide in men with advanced prostate cancer: Subgroup analysis from the phase 3 HERO study

Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT)

MP27-16 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: DETAILED SAFETY ANALYSIS FROM THE RANDOMIZED PHASE 3 HERO STUDY

PD35-08 ORAL RELUGOLIX FOR ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER: POOLED SAFETY ANALYSES FROM RANDOMIZED CONTROLLED STUDIES

MP83-10 PROSTATE CANCER ACTIVE SURVEILLANCE QUALITY IN LARGE COMMUNITY UROLOGY PRACTICES

Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States

Hereditary cancer risk assessment and genetic testing in the community urology practice setting

LB-S&T-12 OPEN -LABEL PHASE II STUDY EVALUATING THE EFFICACY OF CONCURRENT ADMINISTRATION OF RADIUM RA 223 DICHLORIDE AND ABIRATERONE ACETATE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITH SYMPTOMATIC BONE METASTASES (ERADICATE)

Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States

Real-world study of enzalutamide and abiraterone acetate (with prednisone) tolerability (REAAcT): Results

Phase 1b/2 study of enzalutamide (ENZ) with LY3023414 (LY) or placebo (PL) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) after progression on abiraterone

Suchergebnisse filtern